Equities

Cowealth Medical China Co Ltd

603122:SHH

Cowealth Medical China Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)5.61
  • Today's Change-2.02 / -26.47%
  • Shares traded15.58m
  • 1 Year change-35.29%
  • Beta--
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments187316136
Total Receivables, Net766753564
Total Inventory197205179
Prepaid expenses9411780
Other current assets, total112111
Total current assets1,2551,411970
Property, plant & equipment, net1198288
Goodwill, net------
Intangibles, net7.891.810.94
Long term investments------
Note receivable - long term4.102.693.05
Other long term assets239.8417
Total assets1,4611,5591,121
LIABILITIES
Accounts payable168180128
Accrued expenses414038
Notes payable/short-term debt5411198
Current portion long-term debt/capital leases111214
Other current liabilities, total121825
Total current liabilities286362302
Total long term debt5.691720
Total debt71140131
Deferred income tax------
Minority interest2.110.83(0.07)
Other liabilities, total1.082.383.28
Total liabilities295381325
SHAREHOLDERS EQUITY
Common stock398398299
Additional paid-in capital597597336
Retained earnings (accumulated deficit)167180169
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total5.023.44(7.33)
Total equity1,1671,178796
Total liabilities & shareholders' equity1,4611,5591,121
Total common shares outstanding398398398
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.